About: covid:PMC7371831

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:PMC7371831 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
Creator	Li, Xiaochen Wang, Tao Zheng, Zhishui Zhao, Yang Xu, Ke Hu, Ke Lan, Ke Zhao, Dong Li, Honglin Zhang, Yunting Wang, Mengmei Zeng, Shaolin
is schema:about of	named entity 'white blood cell' named entity 'anti-inflammation' named entity 'ribavirin' named entity 'Leflunomide' named entity 'Remdesivir' named entity 'supportive treatment' named entity 'clinical trial' named entity 'COVID' named entity 'nucleotide analog' named entity 'lymphocytes' named entity 'dual-use' named entity 'Clinical Trial' named entity 'qRT-PCR' named entity 'supportive treatment' named entity 'Leflunomide' named entity 'monoclonal antibodies' named entity 'Pharmaceutical' named entity 'viral mutations' named entity 'pyrimidine' named entity 'lymphocytes' named entity 'treatment group' named entity 'Leflunomide' named entity 'Treatment group' named entity 'CRP' named entity 'albumin' named entity 'control group' named entity 'nucleotide analog' named entity 'blood tests' named entity 'SARS-CoV-2' named entity 'hemoglobin' named entity 'SARS-CoV-2 outbreak' named entity 'urea' named entity 'double-blind, placebo-controlled' named entity 'Biotech' named entity 'infection' named entity 'control group' named entity 'Aspartate transaminase' named entity 'Leflunomide' named entity 'Medication' named entity 'Open-Label' named entity 'COVID' named entity 'traditional Chinese medicine' named entity 'Leflunomide' named entity 'CDC' named entity 'Leflunomide' named entity 'mechanical ventilation' named entity 'People’s Republic of China' named entity 'inflammation' named entity 'Leflunomide' named entity 'chloroquine' named entity 'qRT-PCR' named entity 'Control group' named entity 'placebo' named entity 'randomly assigned' named entity 'ground-glass opacity' named entity 'activated charcoal' named entity 'pyrimidine' named entity 'viral RNA' named entity 'anti-viral' named entity 'China' named entity 'Remdesivir' named entity 'drug administration' named entity 'prodrug' named entity 'ICU' named entity 'drug treatment' named entity 'viral shedding' named entity 'χ2 test' named entity 'anti-HIV' named entity 'RNA-dependent RNA polymerase' named entity 'SARS-CoV-2' named entity 'infection' named entity 'Leflunomide' named entity 'Ebola' named entity 'hydroxychloroquine' named entity 'body temperature' named entity 'heart muscle damage' named entity 'pyrimidine' named entity 'respiratory symptoms' named entity 'clinical symptoms' named entity 'reverse transcriptase' named entity 'antivirals' named entity 'exact test' named entity 'DHODH' named entity 'RNA genome' named entity 'COVID-19' named entity 'Leflunomide' named entity 'nasopharyngeal swabs' named entity 'antiviral'

Attributes

Values

Creator

Li, Xiaochen
Wang, Tao
Zheng, Zhishui
Zhao, Yang
Xu, Ke
Hu, Ke
Lan, Ke
Zhao, Dong
Li, Honglin
Zhang, Yunting
Wang, Mengmei
Zeng, Shaolin

is schema:about of

named entity 'white blood cell'
named entity 'anti-inflammation'
named entity 'ribavirin'
named entity 'Leflunomide'
named entity 'Remdesivir'
named entity 'supportive treatment'
named entity 'clinical trial'
named entity 'COVID'
named entity 'nucleotide analog'
named entity 'lymphocytes'
named entity 'dual-use'
named entity 'Clinical Trial'
named entity 'qRT-PCR'
named entity 'supportive treatment'
named entity 'Leflunomide'
named entity 'monoclonal antibodies'
named entity 'Pharmaceutical'
named entity 'viral mutations'
named entity 'pyrimidine'
named entity 'lymphocytes'
named entity 'treatment group'
named entity 'Leflunomide'
named entity 'Treatment group'
named entity 'CRP'
named entity 'albumin'
named entity 'control group'
named entity 'nucleotide analog'
named entity 'blood tests'
named entity 'SARS-CoV-2'
named entity 'hemoglobin'
named entity 'SARS-CoV-2 outbreak'
named entity 'urea'
named entity 'double-blind, placebo-controlled'
named entity 'Biotech'
named entity 'infection'
named entity 'control group'
named entity 'Aspartate transaminase'
named entity 'Leflunomide'
named entity 'Medication'
named entity 'Open-Label'
named entity 'COVID'
named entity 'traditional Chinese medicine'
named entity 'Leflunomide'
named entity 'CDC'
named entity 'Leflunomide'
named entity 'mechanical ventilation'
named entity 'People’s Republic of China'
named entity 'inflammation'
named entity 'Leflunomide'
named entity 'chloroquine'
named entity 'qRT-PCR'
named entity 'Control group'
named entity 'placebo'
named entity 'randomly assigned'
named entity 'ground-glass opacity'
named entity 'activated charcoal'
named entity 'pyrimidine'
named entity 'viral RNA'
named entity 'anti-viral'
named entity 'China'
named entity 'Remdesivir'
named entity 'drug administration'
named entity 'prodrug'
named entity 'ICU'
named entity 'drug treatment'
named entity 'viral shedding'
named entity 'χ2 test'
named entity 'anti-HIV'
named entity 'RNA-dependent RNA polymerase'
named entity 'SARS-CoV-2'
named entity 'infection'
named entity 'Leflunomide'
named entity 'Ebola'
named entity 'hydroxychloroquine'
named entity 'body temperature'
named entity 'heart muscle damage'
named entity 'pyrimidine'
named entity 'respiratory symptoms'
named entity 'clinical symptoms'
named entity 'reverse transcriptase'
named entity 'antivirals'
named entity 'exact test'
named entity 'DHODH'
named entity 'RNA genome'
named entity 'COVID-19'
named entity 'Leflunomide'
named entity 'nasopharyngeal swabs'
named entity 'antiviral'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software